Madrid

• Eficacy of epidural analgesia initiated with dural puncture epidural technic for labour with ultra-low concentration of levobupivacaine. Pending
  2025-522071-28-00 6 Pregnant women who enter in the delivery room and request epidural ana
• Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis Pending
  2025-522118-21-00 6 Acute Anterior Uveitis
• A PHASE 1/1B, OPEN-LABEL, MULTICENTER, FIRST-IN-HUMAN DOSE ESCALATION AND DOSE EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMAC … Pending
  2025-522148-42-00 1 Advanced Solid Tumours
• Study to assess the efficacy and safety of Rina-S plus standard of care compared to standard of care for maintenance treatment of participan … Pending
  2025-522167-15-00 5 Ovarian Cancer Platinum-Sensitive Ovarian Cancer (PSOC)
• Phase 1/2 study to investigate the safety and preliminary efficacy of GSK5460025 alone or in combination with other anti-cancer agents in dM … Pending
  2025-522318-21-00 7 Neoplasms, Colorectal
• A Study to Evaluate the Long-term Safety and Tolerability of Admilparant in Participants with Pulmonary Fibrosis. Pending
  2025-522373-10-00 5 Progressive pulmonary fibrosis and Idiopathic pulmonary fibrosis
• Clinical trial to evaluate the efficacy of early administration of botulinum toxin in open abdominal closure. Pending
  2025-522410-23-00 6 open abdomen
• An Open Label Study to Assess the Effect of Patient Use and Robustness on Tiotropium Bromide Spray 2.5μg, Soft Mist Inhaler device Pending
  2025-522412-16-00 3 Chronic obstructive pulmonary disease
• A phase 2, Multicenter Study of TILs Treatment in Germ Cell tumors: the ARES Study Pending
  2025-522427-10-00 4 Germ Cell Tumors refractory to salvage chemotherapy
• Phase I-IIa, national, multicenter, clinical trial to evaluate the safety and preliminary efficacy of CAR-T CD19 therapy in patients with re … Pending
  2025-522449-23-00 9 Refractory Lupus Nephritis
• A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (P … Pending
  2025-522471-28-00 5 psoriatic arthritis (PsA)
• LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2 Pending
  2025-522475-28-00 5 Pulmonary Hypertension (PH) with Heart Failure with preserved left ven
• A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma Pending
  2025-522523-96-00 1 T-cell Non-Hodgkin Lymphoma
• A Phase 1, Randomized, Placebo-controlled Study with a Double-blind Period with Open-label Extension Period to Evaluate the Safety, Tolerabi … Pending
  2025-522582-30-00 1 Alzheimer’s Disease
• A Phase 3, Long-Term Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Zasocitinib in Subjects with Active Pso … Pending
  2025-522586-30-00 5 Psoriatic Arthritis
• A randomized double blind placebo controlled study of TAK-360 for the treatment of narcolepy with cataplexy Pending
  2025-522587-33-00 4 Narcolepsy with Cataplexy (NT1)
• Proof-of-Concept Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of Intranasal Cenegermin in Adult Participants … Pending
  2025-522692-29-00 4 Subacute Moderate to Severe Traumatic Brain Injury (TBI)
• A Phase 1/2 Study of Inhaled KB707 in Patients Pending
  2025-522723-98-00 9 solid tumor
• Dose determination study of Phleum pratense allergenic extract for immunotherapy treatment, administered via sublingual route, standardized … Pending
  2025-522730-31-00 4 Allergic rhinitis/rhinoconjunctivitis caused by grass polen allergy
• Phase 3 Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Platinum Resistant Ovarian Cancer With Cyclin E1 Overexpression Pending
  2025-522748-42-00 5 Ovarian cancer
• CARESS Study: Cabergoline for the Reduction of Endometriosis Symptoms and Lesion Size Pending
  2025-522812-18-00 11 Endometriosis
• A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell L … Pending
  2025-522818-23-00 5 Small Cell Lung Cancer (SCLC)
• A Study of Vepugratinib (LY3866288) in Participants with Cancer in the Urinary Tract ( FORAGER-2 ) Pending
  2025-522855-25-00 5 Urinary Bladder Neoplasms
• An Open-label Study of Azetukalner in Bipolar I or II Depression Pending
  2025-522872-10-00 5 Depressive episodes associated with Bipolar disorder I or II (Bipolar

Showing 145–168 of 3,599 trials